Among all LR communication partners that were screened in BRCA BoM datasets, only COL3A1 had higher expression in c9 fibroblasts derived from tumor samples compared to c9 fibroblasts derived from other samples (Figure 8E). The gene discussed is COL3A1; the disease is neoplasm.